Sergio Raposeiras-Roubín, Emad Abu-Assi, Tamara Fernández Sanz, Cristina Barreiro Pardal, Isabel Muñoz Pousa, Maria Melendo Viu, Pablo Domínguez Erquicia, Ana Ledo Piñeiro, Andrea Lizancos Castro, Inmaculada González Bermúdez, Xavier Rosselló, Borja Ibáñez, Andrés Íñiguez Romo
INTRODUCTION AND OBJECTIVES: The impact of cancer on clinical outcomes in patients with atrial fibrillation (AF) is unclear. The aim of this study was to assess how cancer influences the prediction and risk of embolic and hemorrhagic events in patients with AF. METHODS: The study population comprised 16 056 patients from a Spanish health area diagnosed with AF between 2014 and 2018. Of these, 1137 (7.1%) had a history of cancer. During a median follow-up of 4.9 years, we assessed the relationship between cancer and bleeding and embolic events by competing risk analysis, considering death as a competing risk...
September 19, 2022: Revista Española de Cardiología